Literature DB >> 11523838

The structure of negative emotions in adolescents.

P Muris1, H Schmidt, H Merckelbach, E Schouten.   

Abstract

This study examined the structure of negative emotions in a sample of nonclinical adolescents, using an approach that exclusively relied on child self-report. A large sample of adolescents (N = 968) completed self-report questionnaires measuring symptoms of fear, anxiety, and depression. Confirmatory factor analysis provided support for the notion that fear, anxiety, and depression are distinct yet correlated components of negative emotions. This result is in agreement with recent empirical findings and current theoretical notions on the structure of negative emotions in children and should be taken as an encouragement for researchers to develop more specific measures for assessing fear, anxiety, and depression in children.

Entities:  

Mesh:

Year:  2001        PMID: 11523838     DOI: 10.1023/a:1010361913186

Source DB:  PubMed          Journal:  J Abnorm Child Psychol        ISSN: 0091-0627


  19 in total

1.  Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale.

Authors:  B F Chorpita; L Yim; C Moffitt; L A Umemoto; S E Francis
Journal:  Behav Res Ther       Date:  2000-08

2.  Structure of anxiety symptoms among children: a confirmatory factor-analytic study.

Authors:  S H Spence
Journal:  J Abnorm Psychol       Date:  1997-05

3.  Some Theory and Applications of Confirmatory Second-Order Factor Analysis.

Authors:  D Rindskopf; T Rose
Journal:  Multivariate Behav Res       Date:  1988-01-01       Impact factor: 5.923

4.  The structure of specific phobia symptoms among children and adolescents.

Authors:  P Muris; H Schmidt; H Merckelbach
Journal:  Behav Res Ther       Date:  1999-09

5.  The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics.

Authors:  B Birmaher; S Khetarpal; D Brent; M Cully; L Balach; J Kaufman; S M Neer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-04       Impact factor: 8.829

6.  Reliability and validity of the Revised Fear Surgery Schedule for Children (FSSC-R).

Authors:  T H Ollendick
Journal:  Behav Res Ther       Date:  1983

7.  The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders.

Authors:  E J Costello; A Angold; B J Burns; D K Stangl; D L Tweed; A Erkanli; C M Worthman
Journal:  Arch Gen Psychiatry       Date:  1996-12

8.  Anxiety and depression in children and adolescents: negative affectivity and the utility of self-reports.

Authors:  C J Lonigan; M P Carey; A J Finch
Journal:  J Consult Clin Psychol       Date:  1994-10

9.  Testing a tripartite model: I. Evaluating the convergent and discriminant validity of anxiety and depression symptom scales.

Authors:  D Watson; K Weber; J S Assenheimer; L A Clark; M E Strauss; R A McCormick
Journal:  J Abnorm Psychol       Date:  1995-02

Review 10.  Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications.

Authors:  L A Clark; D Watson
Journal:  J Abnorm Psychol       Date:  1991-08
View more
  3 in total

1.  A test of the tripartite model of anxiety and depression in elementary and high school boys and girls.

Authors:  Heather A K Jacques; Eric J Mash
Journal:  J Abnorm Child Psychol       Date:  2004-02

2.  The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents.

Authors:  Peter Muris; Ellin Simon; Hester Lijphart; Arjan Bos; William Hale; Kelly Schmeitz
Journal:  Child Psychiatry Hum Dev       Date:  2017-02

3.  Intolerance of COVID-19-Related Uncertainty and Negative Emotions among Chinese Adolescents: A Moderated Mediation Model of Risk Perception, Social Exclusion and Perceived Efficacy.

Authors:  Qi Li; Ronglei Luo; Xiaoya Zhang; Guangteng Meng; Bibing Dai; Xun Liu
Journal:  Int J Environ Res Public Health       Date:  2021-03-11       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.